Trade Summary

5 days ago, Barrow Robert, serving as CEO at Mind Medicine (Mindmed) Inc. (MNMD), sold 25,791 shares at $13.15 per share, for a total transaction value of $339,072.00. Following this transaction, Barrow Robert now holds 778,477 shares of MNMD.

This sale represents a 3.00% decrease in Barrow Robert's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, December 26, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 3 days after the trade was made.

Mind Medicine (Mindmed) Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.